Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
EU approval for Alexion's PNH drug Ultomiris
The European Commission has approved Alexion Pharmaceuticals' Ultomiris (ravulizumab) for the treatment of some adults with the ultra-rare blood disorder paroxysmal nocturnal haemoglobinur...
Janssen hands back rights to Hanmi's diabetes/obesity drug
Shares in Hanmi Pharmaceutical have taken a hit after Johnson & Johnson's Janssen handed back rights to HM12525A, a novel biologic GLP-1/Glucagon dual receptor agonist being developed for weig...
ViiV secures EU nod for HIV therapy Dovato
European regulators have approved ViiV Healthcare's Dovato (dolutegravir and lamivudine), a new once-daily, single-pill, two-drug regimen for the treatment of HIV-1 infection.
Pharma Company Sues FDA for Requiring Deadly Tests on Dogs
Vanda Pharmaceuticals is taking legal action against the U.
Karyopharm Therapeutics prices blood cancer treatment after FDA approval
(Reuters) - Karyopharm Therapeutics Inc on Wednesday set a list-price for its blood cancer treatment Xpovio at $22,000 per month, following accelerated approval from the U.
'Man's best friend' is a robot dog to some with dementia
THOUSAND OAKS, Calif.
Another Biotech Plant Explosion in China Kills Six
Six people were killed in an explosion in a biotech plant in central China last Wednesday.
New Australian flu vaccine developed by AI to undergo clinical trials
CANBERRA, July 2 (Xinhua) -- Australian researchers who have developed a more effective flu vaccine have said that it will undergo clinical trials in the United States.
Elizabeth Holmes will officially go to trial next summer
Sporting a new curly blowout, the disgraced Theranos founder appeared in court Friday, where a judge ruled the case against her will go to trial Aug.
Blast of water could shrink an enlarged prostate as effectively as surgery - and with fewer side-effects
A blast of water could shrink an enlarged prostate as effectively as surgery, but with fewer side-effects, a new trial suggests.
Study connects low social engagement to amyloid levels and cognitive decline
Social relationships are essential to aging well; research has shown an association between lack of social engagement and increased risk of dementia.
Soliris approved to treat neuromyelitis optica spectrum disorder
(HealthDay)—The U.
360
361
362
363
364
365
366
367
368
